Amount of DNA in plasma and cancer risk: A prospective study

International Journal of Cancer

Volumn 111, Issue 5, 2004, Pages 746-749

  Gormally, Emmanuelle ^a   Hainaut, Pierre ^a   Caboux, Elodie ^a   Airoldi, Luisa ^b   Autrup, Herman ^c   Malaveille, Christian ^a   Dunning, Alison ^d   Garte, Seymour ^e   Matullo, Giuseppe ^f   Overvad, Kim ^g,h   Tjonneland, Anne ⁱ   Clavel Chapelon, Francoise ^j   Boffetta, Paolo ^k   Boeing, Heiner ^l   Trichopoulou, Antonia ^m   Palli, Domenico ⁿ   Krogh, Vittorio ^o   Tumino, Rosario ^p   Panico, Salvatore ^q   Bueno De Mesquita, H Bas ^r   Peeters, Petra H ^s   Lund, Eiliv ^t   Gonzalez, Carlos A ^u   Martinez, Carmen ^v   Dorronsoro, Miren ^c   Barricarte, Aurelio ^w   Tormo, M Jose ^x   Quiros, J Ramón ^y   Berglund, Goran ^z   Hallmans, Goran ^aa   Day, Nicholas E ^ab   Key, Timothy J ^ac   Veglia, Fabrizio ^f   Peluso, Marco ⁿ   Norat, Teresa ^a   Saracci, Rodolfo ^a   Kaaks, Rudolf ^a   Riboli, Elio ^a   Vineis, Paolo ^f,ad   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Dept of Occup and Environ Med ^*  (Spain)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e Genetics Research Institute   (Italy)

^f ISI FOUNDATION   (Italy)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^j INSTITUT GUSTAVE ROUSSY   (France)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁿ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p CIVILE M P AREZZO HOSPITAL   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^s UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^t UNIVERSITY OF TROMSØ   (Norway)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^v ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x Instituto Murciano de Investigación Biosanitaria Arrixaca   (Spain)

^y Sección de Promoción de la Salud Consejería de Salud y Servicios Sanitarios de Asturias   (Spain)

^z LUND UNIVERSITY   (Sweden)

^aa UMEÅ UNIVERSITY   (Sweden)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Cancer; Molecular repidemiology; Plasmatic DNA; Prospective studies

Indexed keywords

DNA;

ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; LARYNX CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MOUTH CANCER; PHARYNX CANCER; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; CASE-CONTROL STUDIES; DNA; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 4043074258     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20327     Document Type: Article

References (10)

1. Hu YC, Sidransky D, Ahrendt SA. Molecular detection approaches for smoking associated tumors. Oncogene 2002;21:7289-97.
2. Sidransky D. Advances in cancer detection. Sci Am 1996;275:104-9.
3. Anker P, Stroun M. Circulating DNA in plasma or serum. Medicina (B Aires) 2000;60:699-702.
4. Beau-Faller M, Gaub MP, Schneider A, Ducrocq X, Massard G, Gasser B, Chenard MP, Kessler R, Anker P, Stroun M, Weitzenblum E, Pauli G, Wihlm JM, Quoix E, Oudet P. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int J Cancer 2003;105:361-70.
5. Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih I. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 2002;94:1697-703.
6. Holdenrieder S, Stieber P, Forg T, Kuhl M, Schulz L, Busch M, Schalhorn A, Seidel D. Apoptosis in serum of patients with solid tumours. Anticancer Res 1999;19:2721-4.
7. Sozzi G, Conte D, Mariani L, Lo VS, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001;61:4675-8.
8. Riboli E, Kaaks R. The EPIC project: rationale and study design. Int J Epidemiol 1997;26(Suppl 1):S6-14.
9. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, Trepo C, Brechot C, Hainaut P, Montesano R. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the gambia. J Natl Cancer Inst 2000;92:148-53.
10. Gallagher A, Armstrong AA, MacKenzie J, Shield L, Khan G, Lake A, Proctor S, Taylor P, Clements GB, Jarrett RF. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999;84:442-8.